Johnson & Johnson study shows XARELTO® Plus Aspirin Significantly Reduced Total Ischemic Events
Phase 3 VOYAGER PAD is the first investigational study in 20 years to highlight the benefit ...
Read more
Tag: Johnson & Johnson
Johnson & Johnson COVID-19 Vaccine Roll-out to Resume in Europe Following EMA Review
Johnson & Johnson announced that the European Medicines Agency's (EMA) Pharmacovigilance Risk Assessment Committee (PRAC) has ...
Read more